FDA approves first venous stent for IVC and iliofemoral veins, offering a new treatment for deep venous disease with proven 12-month patency.

W. L. Gore & Associates has secured FDA approval for the GORE VIABAHN FORTEGRA Venous Stent — previously known as the GORE ...

Enrollment milestone achieved ahead of schedule as Solaris DE drug-eluting continues to gather additional clinical ...

While existing vascular stents, made of metal, come in different sizes to accommodate a variety of patients, a new technology offers complete personalization according to an individual’s precise ...

Please provide your email address to receive an email when new articles are posted on . A balloon-expandable vascular stent was useful in children with CV lesions and allowed implantation in distal ...

Vascular stent implantation is feasible and likely to provide clinical benefit in select patients who have central vascular obstruction due to fibrosing mediastinitis (FM), according to the first ...

In the United States, heart disease is the leading cause of death among adults. Vascular stents are vital medical devices that are used to ensure patients increase their life expectancy and lead ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the U.S. Food and Drug Administration (FDA) approval of the GORE® TIGRIS® Vascular Stent, a dual-component stent ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHILADELPHIA -- ...

NEW YORK, May 12, 2021 /PRNewswire/ — The global peripheral vascular stents market by product (Self-expanding, balloon-expanding, and drug-eluting), geography (North America, Europe, Asia, and ROW), ...

LONDON--(BUSINESS WIRE)--The peripheral vascular stents market is poised to grow by USD 1.22 billion during 2020-2024 progressing at a CAGR of almost 8% during the forecast period. Worried about the ...

FLAGSTAFF, Ariz., W. L. Gore & Associates, Inc. (Gore) today announced the U.S. Food and Drug Administration (FDA) approval of the GORE® TIGRIS® Vascular Stent, a dual-component stent with a unique ...